|
|
CID51281 |
Benefix; Benefix - (250iu); Benefix - (500iu); Benefix -(1000iu); Coagulation factor ix (recombinant); Coagulation factor ix recombinant human; Factor ix (recombinant); Idelvion; Ixinity; Nonacog alfa; Recombinant factor ix; Rixubis |
DrugBank |
7 |
NA |
|
|
CID51282 |
Pdgf-bb; Becaplermin; C-sis; Pdgf b-chain; Pdgf-2; Pdgfb; Platelet-derived growth factor b chain precursor; Platelet-derived growth factor beta polypeptide; Regranex; Sh-polypeptide-59 |
DrugBank; STITCH; Ramilowski |
7 |
RID03454 |
|
|
CID51283 |
Interferon alfa-2b; Interferon alfa-2b, recombinant; Interferon α-2b; Intron (interferon α2b); Intron a; Intron a - kit (pws+diluent) 3000000iu/vial; Intron a - kit (pws+diluent) 5000000iu/vial; Intron a (interferon α2b); Intron a inj 10000000unit/vial; Intron a inj 3000000unit/vial; Intron a inj 5000000unit/vial; Rifn-alpha-2b |
DrugBank |
2 |
NA |
|
|
CID51284 |
Abarelix |
DrugBank; CLUE; STITCH |
1 |
NA |
|
|
CID51285 |
Oxytocin; Oxytocin injection; Pitocin |
DrugBank; CLUE |
5 |
NA |
|
|
CID51286 |
Anti-alpha4 integrin; Anti-vla4; Natalizumab; Tysabri |
DrugBank |
12 |
NA |
|
|
CID51287 |
Enfuvirtide; Envelope polyprotein gp160 precursor [contains: exterior membrane glycoprotein,gp120, transmembrane glycoprotein,gp41]; Fuzeon |
DrugBank |
1 |
NA |
|
|
CID51288 |
Anti-rsv; Palivizumab; Synagis |
DrugBank |
11 |
NA |
|
|
CID51289 |
Dacliximab; Daclizumab; Daclizumab beta; Zinbryta; Zinbryta pen |
DrugBank |
12 |
NA |
|
|
CID51290 |
Antivegf; Avastin; Bevacizumab; Bevacizumab-awwb |
DrugBank |
11 |
NA |
